BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19372564)

  • 1. Tautomycetin and tautomycin suppress the growth of medullary thyroid cancer cells via inhibition of glycogen synthase kinase-3beta.
    Adler JT; Cook M; Luo Y; Pitt SC; Ju J; Li W; Shen B; Kunnimalaiyaan M; Chen H
    Mol Cancer Ther; 2009 Apr; 8(4):914-20. PubMed ID: 19372564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
    Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
    Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MK-2206 causes growth suppression and reduces neuroendocrine tumor marker production in medullary thyroid cancer through Akt inhibition.
    Burke JF; Schlosser L; Harrison AD; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2013 Nov; 20(12):3862-8. PubMed ID: 23900743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leflunomide suppresses growth in human medullary thyroid cancer cells.
    Alhefdhi A; Burke JF; Redlich A; Kunnimalaiyaan M; Chen H
    J Surg Res; 2013 Nov; 185(1):212-6. PubMed ID: 23816245
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of specific protein phosphatase inhibitors, tautomycin and tautomycetin toward structure-activity relationship study.
    Oikawa H
    Curr Med Chem; 2002 Nov; 9(22):2033-53. PubMed ID: 12369869
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Suberoyl bishydroxamic acid activates notch1 signaling and suppresses tumor progression in an animal model of medullary thyroid carcinoma.
    Ning L; Jaskula-Sztul R; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2008 Sep; 15(9):2600-5. PubMed ID: 18563491
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Resveratrol induces Notch2-mediated apoptosis and suppression of neuroendocrine markers in medullary thyroid cancer.
    Truong M; Cook MR; Pinchot SN; Kunnimalaiyaan M; Chen H
    Ann Surg Oncol; 2011 May; 18(5):1506-11. PubMed ID: 21184191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth in medullary thyroid cancer cells with histone deacetylase inhibitors and lithium chloride.
    Adler JT; Hottinger DG; Kunnimalaiyaan M; Chen H
    J Surg Res; 2010 Apr; 159(2):640-4. PubMed ID: 19394967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptosis-mediated medullary thyroid cancer growth suppression by the PI3K inhibitor LY294002.
    Kunnimalaiyaan M; Ndiaye M; Chen H
    Surgery; 2006 Dec; 140(6):1009-14; discussion 1014-5. PubMed ID: 17188151
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Valproic acid activates Notch1 signaling and induces apoptosis in medullary thyroid cancer cells.
    Greenblatt DY; Cayo MA; Adler JT; Ning L; Haymart MR; Kunnimalaiyaan M; Chen H
    Ann Surg; 2008 Jun; 247(6):1036-40. PubMed ID: 18520232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glycogen synthase kinase--3β inhibitors suppress leukemia cell growth.
    Song EY; Palladinetti P; Klamer G; Ko KH; Lindeman R; O'Brien TA; Dolnikov A
    Exp Hematol; 2010 Oct; 38(10):908-921.e1. PubMed ID: 20540984
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1.
    Chen H; Kunnimalaiyaan M; Van Gompel JJ
    Thyroid; 2005 Jun; 15(6):511-21. PubMed ID: 16029117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CEP-701 and CEP-751 inhibit constitutively activated RET tyrosine kinase activity and block medullary thyroid carcinoma cell growth.
    Strock CJ; Park JI; Rosen M; Dionne C; Ruggeri B; Jones-Bolin S; Denmeade SR; Ball DW; Nelkin BD
    Cancer Res; 2003 Sep; 63(17):5559-63. PubMed ID: 14500395
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tumor growth inhibition by indomethacin in a mouse model of human medullary thyroid cancer: implication of cyclooxygenases and 15-hydroxyprostaglandin dehydrogenase.
    Quidville V; Segond N; Pidoux E; Cohen R; Jullienne A; Lausson S
    Endocrinology; 2004 May; 145(5):2561-71. PubMed ID: 14736730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
    Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
    Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein phosphatase 1-dependent dephosphorylation of Akt is the prime signaling event in sphingosine-induced apoptosis in Jurkat cells.
    Thayyullathil F; Chathoth S; Shahin A; Kizhakkayil J; Hago A; Patel M; Galadari S
    J Cell Biochem; 2011 Apr; 112(4):1138-53. PubMed ID: 21308747
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Small-molecule inhibitors of ser/thr protein phosphatases: specificity, use and common forms of abuse.
    Swingle M; Ni L; Honkanen RE
    Methods Mol Biol; 2007; 365():23-38. PubMed ID: 17200551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hypertonic stress activates glycogen synthase kinase 3beta-mediated apoptosis of renal medullary interstitial cells, suppressing an NFkappaB-driven cyclooxygenase-2-dependent survival pathway.
    Rao R; Hao CM; Breyer MD
    J Biol Chem; 2004 Feb; 279(6):3949-55. PubMed ID: 14607840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tautomycin: an inhibitor of protein phosphatases 1 and 2A but not a tumor promoter on mouse skin and in rat glandular stomach.
    Suganuma M; Okabe S; Sueoka E; Nishiwaki R; Komori A; Uda N; Isono K; Fujiki H
    J Cancer Res Clin Oncol; 1995; 121(9-10):621-7. PubMed ID: 7559747
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifungal activity of tautomycin and related compounds against Sclerotinia sclerotiorum.
    Chen X; Zhu X; Ding Y; Shen Y
    J Antibiot (Tokyo); 2011 Aug; 64(8):563-9. PubMed ID: 21772304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.